We tested the hypothesis that the effects of GABAergic agonists on behavior and the electroencephalogram (EEG) result from an increased regional synchronization in cortical circuits. The relationship between regional EEG topography, EEG synchronization and alteration of behavior was investigated by administering male C57BL/6 mice (n=7) a high, 3 mg/kg i.p. dose of muscimol, a selective GABA A agonist.
Introduction
Electrical activity of the brain is determined by specific interactions between billions of excitatory and inhibitory neurons of the neocortex and subcortical structures.
All major oscillations in the electroencephalogram (EEG), namely delta, theta, spindle and gamma frequencies, arise from synchronous neuronal activity in the neocortex, thalamus, hippocampus and other brain structures, where GABAergic interneurons play an important role (Steriade et al., 1990 , von Krosigk et al., 1993 , Steriade and Amzica, 1998 , Bland et al., 1999 , Chapman and Lacaille, 1999 .
Regional EEG differences are present during waking and sleep in humans and rodents. These differences are enhanced after prolonged wakefulness and are thought to reflect use-dependent processes (Huber et al., 2000 , Vyazovskiy et al., 2000 , Vyazovskiy et al., 2006 . Regional EEG dynamics during sleep have not only a functional but also a morphological basis. Thus, EEG recordings in acallosal mice which have enhanced neocortical connectivity in the rostral part of the hemisphere due to the Probst bundle, showed higher frontal EEG power at approximately 1 Hz at the expense of the remaining delta frequencies . Based on such results we proposed that there is a link between local changes of EEG power and regional neuronal synchronization .
The level of regional synchronization might be an important factor underlying vigilance. In contrast to waking, during which cortical activity is activated, behavioral states characterized by high EEG synchrony, such as non-rapid eye movement (NREM) sleep or absence seizures, are accompanied by reduced responsiveness, immobility and loss of consciousness. Neurophysiological mechanisms underlying the relationship 6 between regional synchronization and the behavioral state are unresolved, though there is considerable evidence that GABA-mediated inhibition might be involved.
GABAergic agonists elicit sedation and sleep (Nelson et al., 2002 , Reynolds et al., 2003 , Mohler, 2006 , Rudolph and Mohler, 2006 , but the neurophysiologic mechanisms underlying their hypnotic properties remain unknown (Nelson et al., 2002) .
A large body of evidence suggests that the sedative and/or hypnotic action of GABA A agonists is associated with increased cortical synchronization in the low EEG frequencies. Thus, in rats muscimol induced sedation and catalepsy (reviewed in DeFeudis, 1980) and an increase of low EEG frequencies (2-6 Hz) in NREM sleep (Lancel et al., 1996 , Lancel et al., 1997 . These findings are consistent with EEG alterations found in an absence epilepsy-prone rat strain (WAG\Rij), where icv muscimol induced a dose-dependent abnormal EEG pattern consisting of slow waves and spikes which persisted for several hours (Peeters et al., 1989) . Bilaterally synchronous spikewaves appeared after systemic administration of muscimol in the cat (Fariello et al., 1981) , while in the baboon Papio papio, muscimol induced spike-wave complexes (Pedley et al., 1979) similar to the EEG changes elicited by 5 mg/kg muscimol in patients suffering from Huntington's disease (Shoulson et al., 1978) . Other behavioral effects of muscimol were prolongation of propofol-induced anesthesia in mice (Irifune et al., 2003) , and a dose-dependent increase in the duration of spontaneous petit mal-like seizures in the rat (Vergnes et al., 1984) . Taken together, these observations suggest that neuronal synchronization, underlying the generation of low EEG frequencies is markedly increased after administration of potent GABA A receptor agonists. 7 We tested the hypothesis that behavioral alterations, such as sedation and reduced locomotion elicited by GABA A agonists, are accompanied by changes in regional EEG topography and EEG synchronization in low frequencies. We used muscimol because it is a powerful GABA A agonist and tested its effects on behavior and the EEG in mice.
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Experimental procedures
Animals. The experiments were performed in accordance with the European Communities Council Directive of 24 November 1986 (86/609/EEC) and were approved by the Cantonal Veterinary Office of Zurich. All efforts were made to minimize the number of mice used and their suffering. Male C57BL/6 mice (n=7) (Harlan Netherlands, B.V.) were operated at 12.6 ± 0.2 weeks (weighing 25.5 ± 0.6 g at surgery). The mice were kept individually in Macrolon cages (36 x 20 x 35 cm), equipped with running wheels (Vyazovskiy et al., 2006) to investigate voluntary locomotor activity. Food and water were available ad libitum, and the mice were maintained on a 12 h light -12 h dark cycle (daylight type fluorescent tubes, 58 W, approximately 30 lux) at a constant ambient temperature (22-24°C) .
Surgery. Stainless steel electrodes (0-80 x 1/8; Plastics One® Inc., Roanoke, Virginia, USA) for EEG recording were implanted epidurally under deep anesthesia (ketamin 87 mg/kg -xylazin 13 mg/kg, i.p.) over the right frontal cortex (2 mm anterior to bregma, 1.5 mm lateral to the midline; Paxinos and Franklin, 2001) , and over the right parietal cortex (3 mm posterior to bregma, 2 mm lateral to midline) and as reference over the cerebellum (~ 2 mm posterior to lambda, on the midline). The electrodes were connected to stainless steel wires and fixed to the skull with dental cement. Two gold wires (diameter 0.2 mm) were inserted into the neck muscles to record the electromyogram (EMG). After surgery the mice were connected by a fine cable to the amplifier via a swivel, and remained connected during the entire experiment. At least 3 weeks were allowed for recovery and adaptation to the recording conditions. Experimental protocol and data analysis. The experimental group of mice, implanted with EEG electrodes (n=7, see below) was injected i.p. with vehicle and after at least 4 days, with 3 mg/kg muscimol. This design was chosen to avoid the potential long-term effects of muscimol on the EEG, precluding a reliable comparison with the effects of vehicle on behavior and the EEG. Muscimol (Tocris Cookson Ltd., Bristol, UK) was dissolved in physiological pyrogen-free saline (0.9% NaCl; vehicle). Injections occurred 3 h after light onset.
The 3 mg/kg dose was chosen based on a behavioral pilot study, where the effects of two doses (2 mg/kg i.p., n=14, and 1 mg/kg, n=4,) were evaluated. Both doses reduced locomotor activity within 15 min post-injection. All mice were sedated, with eyes open and displaying an extended, rigid body posture and elongated tail, behaviors typical for a catalepsy-like state. The effect lasted between 40-150 min, recovery occurring more rapidly after the lower dose (30-60 min). In a few mice, muscimol induced myoclonic jerks of the hind limbs, as described by Menon and Vivonia, 1981 .
Furthermore, we assessed in n=5 of the 14 mice receiving 2 mg/kg muscimol, the ability to respond to multimodal sensory stimuli (tapping the cage once) applied every 15 min during catalepsy. Arousal responses such as head or ear movements or a body jolt were observed in all mice. Since the aim of the study was to test the hypothesis that behavioral changes are related to the regional EEG pattern, we chose 3 mg/kg to make sure that reliable, prolonged catalepsy and hyperactivity phases would be induced.
Continuous EEG, time-lapse video recordings, infrared (IR) -and running-wheel (RW)-activity recordings were obtained (n=7). RW-revolutions and activity counts were integrated over consecutive 1-min epochs and stored on a computer, as described previously ; Chronobiology Kit, Standford Software System, Stanford, California). Vigilance states were visually scored for 4-s epochs on the basis of the raw parietal EEG, slow-wave activity (SWA, EEG power between 0.75-4.0 Hz) and the EMG (Tobler et al., 1997) . In the first 1-2 h after muscimol administration the waking and NREM sleep EEG were sometimes indistinguishable. Vigilance states were then determined based on the EMG, IR-activity and the behavioral scoring of the video tapes. Epochs containing EEG artifacts in either derivation were visually identified and excluded from spectral analysis of both derivations (7.71.4 % of 12 h).
EEG wave and cross-correlation analysis. The incidence and amplitude of EEG waves were investigated in the 3 h before and after injection of muscimol. EEG half-waves were defined based on zero-crossings of the EEG signal after band-pass filtering of delta frequencies (0.5-4.0 Hz; stop band edge frequencies 0.1 and 8.0 Hz, respectively). Wave incidence was the number of peaks detected in the filtered signal within pre-defined amplitude ranges. The amplitude of EEG half-waves was assessed by computing the maximal or minimal voltage (positive and negative half-waves, respectively) between two consecutive zero-crossings. Half-waves shorter than 0.1 seconds and < 10 µV were excluded.
An estimate of the cross-correlation between the frontal and parietal EEG time series was computed based on 4-s epochs (sampling rate 128 Hz) with Matlab function xcorr.
The sequences of correlation coefficients were obtained for all 4-s epochs during muscimol induced catalepsy and for all 4-s epochs in NREM sleep of the corresponding time interval after vehicle. Subsequently, for each 4-s epoch the time difference between lag = 0 of the correlation and the time lag corresponding to the highest correlation value within a 1-s window below or above the lag = 0 was determined.
Before computing averages and for statistical comparisons Fisher's ztransformation was applied to correlation values. The software package Matlab (The Math Works, Inc., Natick, MA, USA) was used for data and signal analysis.
Statistics. The effects of muscimol and vehicle on vigilance states and EEG spectra were compared within each treatment by rANOVAs with factors 'pharmacological treatment' (muscimol and vehicle) and 'time interval', followed by two-tailed paired ttests. The relationship between the duration of the hyperactivity phase or RW intensity and the subsequent level of SWA in NREM sleep was assessed by linear correlation analyses (Pearson). SAS (SAS Institute, Inc., Cary, NC, USA) was used for statistical analysis.
Results

Biphasic behavioral effects of 3 mg/kg muscimol
Muscimol elicited in all mice a particular order of behaviors associated with specific EEG patterns (Fig. 1 ). An initial activation lasting 13.3 ± 1.1 min was characterized by active movement (IR counts/min: 8.7  2.4) and short running bouts (RW counts/min: 9.4 ± 2.6). This phase was followed by a long-lasting suppression of motor activity (IR counts/min: 0.09  0.05; SEM) and subsequent hyperactivity (IR counts/min: 11.5  3.3). Based on the behavioral observations, the inactivity phase was defined as catalepsy. This state lasted 96 min (± 12.4; SEM, range 55-157 minutes). The hyperactivity phase was dominated by vigorous wheel running (RW revolutions/min: 17.9  2.6) lasting 49.7 min (± 5.4; range: 28-69 min). The duration of catalepsy and the intensity of wheel running during hyperactivity were negatively correlated (n=7; r=-0.82, Pearson's correlation coefficient, p=0.02). The behavior of the n=7 EEG mice, and the n=14 + 4 mice of the pilot experiment, changed as a function of the dose. As the dose was increased, inactivity (catalepsy) and hyperactivity was prolonged. Such a biphasic effect was never elicited by the vehicle. Thus, vehicle injection elicited a significantly longer initial activation than muscimol, 35.3 ± 3.1 min (p<0.001), and lower IR-activity (4.4 ± 1.1 counts/min, p=0.08) and RW-activity (4.7 ± 1.1 counts/min, p=0.06). During the time interval corresponding to hyperactivity after muscimol, locomotor activity after vehicle was markedly lower: IR-activity 0.05 ± 0.03 (p<0.05); RW-activity: 0.0 ± 0.0 (p<0.001).
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Major EEG alterations after administration of muscimol
The main EEG feature during catalepsy was a regularly recurring high-voltage wave pattern on a low-voltage background (Fig. 2) . These waves were similar in both derivations and occurred synchronously. As a result, the EEG spectrum during catalepsy did not show the regional differences between the frontal and parietal derivation observed during sleep after vehicle (Fig. 3 ). EEG power < 3 Hz was enhanced during muscimol-induced catalepsy in both derivations, while power > 4 Hz (parietal) or > 8 Hz (frontal) up to 35 Hz was below the values of NREM sleep after vehicle (Fig. 3, top panels) .
During hyperactivity, slow waves resembling NREM sleep slow waves dominated the frontal EEG (Fig. 2) , resulting in a major increase in EEG power in the slow-wave range compared to the parietal derivation (Fig. 3, bottom panels) . In contrast, the parietal EEG exhibited a pronounced peak in the theta frequency range which is characteristic of running behavior (Vyazovskiy et al., 2006) .
A "physiological" sleep pattern with a NREM-REM sleep alternation was reestablished approximately 2.5 h after the muscimol injection corresponding to the end of the hyperactivity phase (Fig. 4) . SWA in NREM sleep was dramatically enhanced immediately after the muscimol-induced hyperactivity. This was the case for both derivations, but especially for the frontal EEG (Fig. 4, bottom panels) . The SWA increase in the first hour after the hyperactivity phase (expressed relative to the preinjection level) was unrelated to the duration of the hyperactivity phase or to the amount of RW-activity (correlation coefficients for duration of hyperactivity: parietal, r=0.12, p=0.8; frontal, -0.31, p=0.5; RW-activity: parietal, r=0.41, p=0.4; frontal, -0.36, p=0.4).
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The phase relationship between slow waves in the frontal and parietal EEG was enhanced after muscimol A striking finding was the synchronous occurrence of high-amplitude waves within both derivations during catalepsy (Fig. 2) . We therefore investigated the amplitude distribution and phase-relationship of EEG waves between the two EEG derivations.
During catalepsy, high amplitude half-waves were more abundant than during preinjection NREM sleep in both derivations (Fig. 5) . During the muscimol-induced catalepsy slow-waves in the frontal EEG showed a stable phase relationship to those of the parietal EEG in all 7 mice (one individual is shown in Fig. 6 A) . To assess this relationship quantitatively and to enable comparison with baseline and post-vehicle NREM sleep two analyses were performed.
First, cross-correlation functions of frontal versus (vs) parietal 4-s EEG epochs
were computed during catalepsy as well as during NREM sleep belonging to the corresponding time interval following vehicle injection. Several peaks appeared on the cross-correlation function during catalepsy (3 peaks of high correlation can be seen in the illustration of a single 4-s epoch in Fig. 6 B) indicating a slow periodic occurrence of synchronous waves after muscimol. In contrast, such synchronous oscillatory activity was weak during NREM sleep (Fig. 6 B, vehicle) . In most 4-s epochs the highest correlation was observed within lag=0 ± 1 s. To assess the strength of the correlation, To investigate the phase relationship between the frontal and parietal waves in more detail, the distribution of time-lags of the maximal value of the cross-correlation function was computed (Fig. 6 D) . After muscimol a single peak was apparent at -0.065 s, indicating that on average slow waves in the parietal derivation were delayed relative to the frontal waves. In contrast, after vehicle as well as during baseline NREM sleep before the injection (not shown), the distribution of the lags was bimodal with peaks at lag ± 0.125 s. Thus, a subset of frontal EEG waves occurred consistently before or after the waves in the parietal EEG, indicating that slow waves originated in some cases in the frontal regions while in others they originated in the parietal derivation. A considerable number of waves occurred simultaneously in both derivations (lag = 0). A redistribution towards an increased number of short lags at the expense of longer lags was apparent after muscimol compared to vehicle (Fig. 6 D) .
Secondly, because muscimol induced typical high amplitude slow waves (see Fig. 2 and 6 A), we performed a single wave analysis to determine the shortest time difference between the peaks of high-amplitude waves (>100µV) of the frontal and parietal EEG (Fig. 6 C) . The mean difference in occurrence of the frontal and parietal waves (independently of whether there was an advance or a delay), was after muscimol shorter than after vehicle (positive half-wave peaks by 26.0 ± 2.5 % SEM; negative half-wave peaks by 26.9 ±2.5 %). 16 We next investigated whether during muscimol-induced catalepsy the frontal high-amplitude waves occurred consistently earlier than in the parietal derivation.
Positive half-wave peaks of the frontal waves on average preceded the positive peaks of the parietal derivation by 83.2 ± 9.2 ms. In contrast, after vehicle the time difference between wave occurrence showed considerable variability (10.4 ± 16.6. ms) and was significantly smaller (muscimol vs vehicle: p<0.01, paired t-test), indicating that after muscimol the phase relationship between the EEG waves of the two derivations was more stable.
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Discussion
We investigated the association between regional EEG topography and EEG synchronization with behavioral states after peripheral administration of a high dose of the GABA A agonist muscimol. This model was well suited because muscimol consistently elicited a succession of two behavioral states: a profound initial motor depression, resembling a catalepsy-like state, followed by a highly activated state characterized by robust wheel running.
We tested the hypothesis that these two pharmacologically induced behavioral states are associated with a distinct regional EEG pattern. Specifically, we expected that in analogy to other quiescent states, such as sleep, the muscimol induced sedation would be associated with increased regional EEG synchronization. Consistent with our hypothesis, we found that during the initial catalepsy-like state, regional EEG differences were virtually abolished. This was a result of the strikingly similar frontal and parietal 17 EEG pattern. The high-amplitude waves dominating the EEG during this state, showed a tighter phase-relationship between the regions. Taken together, it seems that the sedative effects of GABA A agonists and GABA A modulators are related to an increased global synchrony of cortical neuronal activity. These results are consistent with the increased EEG power in the slow-wave range, high-amplitude synchronous EEG waves or spikes observed in the rat (Peeters et al., 1989 , Lancel et al., 1996 , Lancel et al., 1997 , in cats (Fariello et al., 1981) , and in baboon Papio papio (Pedley et al., 1979) .
The catalepsy-like phase, characterized by immobility and abolition of regional EEG differences, was followed by a hyperactivity phase during which the mice consistently engaged in wheel running. The cortical EEG pattern between the frontal and parietal derivation became remarkably dissociated ( Fig. 2 and 3) . Thus, the parietal EEG exhibited high levels of theta-activity, typical for running (Vyazovskiy et al., 2006) , while the frontal slow waves resembled the NREM sleep EEG (Fig. 2) . The succession of the depressed and hyperactivity phase could result from a disbalance between excitatory and inhibitory mechanisms.
Muscimol elicited a dramatic increase of SWA during both the catalepsy and hyperactivity phase. However, during sleep following the hyperactivity phase, SWA was still massively above the levels (a 2-3 fold increase) encountered at the beginning of the light period (Fig. 4 ). While the high SWA level at light onset is the consequence of the considerable amount of spontaneous waking towards the end of the dark period, the remarkable muscimol-induced SWA increase occurred after only a short period of hyperactivity. In contrast to the well-known correlation between waking and SWA (Huber et al., 1999 , Franken et al., 2001 , Vyazovskiy et al., 2006 , the level of SWA at 18 the onset of the recovery phase and the duration of the preceding hyperactivity phase were not correlated. The high SWA level immediately after the hyperactivity phase when NREM-REM sleep cycles reappeared (Fig. 4) and its progressive decline to preinjection levels, suggests that normal physiological sleep is necessary to dissipate the sleep pressure which apparently accumulated, despite the muscimol induced slow waves. Consistent with this interpretation, the time course of SWA during recovery after muscimol induced hyperactivity resembles recovery after sleep deprivation.
Neuronal mechanisms underlying high-amplitude synchronous waves induced by muscimol or by THIP, another GABA A agonist are unknown.
Inhibitory connections play a crucial role in the generation and synchronization of activity in the thalamocortical network (McCormick, 1992 , Kim et al., 1997 . It is possible that high-amplitude waves induced by GABA A agonists arise from the same basic phenomenon -the slow cortical oscillation -as slow waves during sleep (Steriade et al., 1993b, Steriade and Amzica, 1998) . The synchronous occurrence of high-amplitude slow waves across cortical areas elicited by muscimol is consistent with recent data suggesting an important role of inhibitory neurons in the large-scale synchronization of the slow oscillation (Volgushev et al., 2006) . In addition to the intracortical synchronizing mechanisms, subcortical structures might play an important role in the generation of the EEG pattern after muscimol and THIP. Thus the stimulation of the pedunculopontine tegmental nucleus or locus coeruleus blocked cyclic hyperpolarization-depolarization components of the slow oscillations, leading to EEG activation, thereby increasing power in faster frequencies and lowering power between 0-8 Hz (Steriade et al., 1993a) .
Our results are consistent with the notion that EEG synchronization is associated with 19 high values of SWA. Muscimol injection led to a redistribution of spectral EEG power towards lower EEG frequencies at the expense of higher frequencies above 4-8 Hz.
Muscimol may act both in the neocortex, where it plays a role in synchronization of the slow cortical oscillation, and at subcortical structures which maintain the cortex in an activated state.
In conclusion, we demonstrate that muscimol abolished regional differences and enhanced phase-relationship between EEG waves in the two cortical regions. These results suggest that GABAergic mechanisms play an important role in regional cortical synchronization. In addition, the global level of synchrony in neocortical networks might determine behavioral states. x 'time-lag').
